Structure–activity relationships of diphenyl-ether as protoporphyrinogen oxidase inhibitors: insights from computational simulations

Protoporphyrinogen oxidase (PPO, EC 1.3.3.4), which has been identified as a significant target for a great family of herbicides with diverse chemical structures, is the last common enzyme responsible for the seventh step in the biosynthetic pathway to heme and chlorophyll. Among the existing PPO inhibitors, diphenyl-ether is the first commercial family of PPO inhibitors and used as agriculture herbicides for decades. Most importantly, diphenyl-ether inhibitors have been found recently to possess the potential in Photodynamic therapy (PDT) to treat cancer. Herein, molecular dynamics simulations, approximate free energy calculations and hydrogen bond energy calculations were integrated together to uncover the structure–activity relationships of this type of PPO inhibitors. The calculated binding free energies are correlated very well with the values derived from the experimental ki data. According to the established computational models and the results of approximate free energy calculation, the substitution effects at different position were rationalized from the view of binding free energy. Some outlier (e.g. LS) in traditional QSAR study can also be explained reasonably. In addition, the hydrogen bond energy calculation and interaction analysis results indicated that the carbonyl oxygen on position-9 and the NO2 group at position-8 are both vital for the electrostatic interaction with Arg98, which made a great contribution to the binding free energy. These insights from computational simulations are not only helpful for understanding the molecular mechanism of PPO-inhibitor interactions, but also beneficial to the future rational design of novel promising PPO inhibitors.

[1]  P. Kollman,et al.  How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000 .

[2]  F. Hess Light-dependent herbicides: an overview. , 2000 .

[3]  F. Dayan,et al.  Predicting the activity of the natural phytotoxic diphenyl ether cyperine using Comparative Molecular Field Analysis , 2000 .

[4]  E. Kruse,et al.  Cloning and characterization of a plastidal and a mitochondrial isoform of tobacco protoporphyrinogen IX oxidase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Paolo Piccardi,et al.  Synthesis and herbicidal activity of novel heterocyclic protoporphyrinogen oxidase inhibitors. , 2004, Pest management science.

[6]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[7]  S. Duke,et al.  Protoporphyrinogen Oxidase as the Optimal Herbicide Site in the Porphyrin Pathway , 1994 .

[8]  Jeremy C. Smith,et al.  Theory and normal-mode analysis of change in protein vibrational dynamics on ligand binding. , 2010, The journal of physical chemistry. B.

[9]  J. Deybach,et al.  Protoporphyrinogen oxidase: complete genomic sequence and polymorphisms in the human gene. , 1996, Biochemical and biophysical research communications.

[10]  S. Duke,et al.  Quantitative structure-activity relationships of protoporphyrinogen oxidase-inhibiting diphenyl ether herbicides , 1992 .

[11]  Yin Tan,et al.  Structural insight into unique properties of protoporphyrinogen oxidase from Bacillus subtilis. , 2010, Journal of structural biology.

[12]  Takaharu Tanaka,et al.  Synthesis of Novel Diphenyl Ether Herbicides , 1995 .

[13]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[14]  J. Camadro,et al.  The domain structure of protoporphyrinogen oxidase, the molecular target of diphenyl ether-type herbicides. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  V. Fingar,et al.  Photodynamic therapy using a protoporphyrinogen oxidase inhibitor. , 1997, Cancer research.

[16]  P. Kollman,et al.  An approach to computing electrostatic charges for molecules , 1984 .

[17]  R. J. Porra,et al.  The enzymic conversion of coproporphyrinogen III into protoporphyrin IX , 1964 .

[18]  K. König,et al.  Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo , 2004, Archives of Dermatological Research.

[19]  P. Kollman,et al.  Atomic charges derived from semiempirical methods , 1990 .

[20]  K. Sharp,et al.  Calculating the electrostatic potential of molecules in solution: Method and error assessment , 1988 .

[21]  A. Cruess,et al.  Photodynamic therapy with verteporfin in age‐related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties , 2009, Acta ophthalmologica.

[22]  G. S. Marks The biosynthesis of heme and chlorophyll , 2008, The Botanical Review.

[23]  K. Moghissi,et al.  Photofrin PDT for early stage oesophageal cancer: long term results in 40 patients and literature review. , 2009, Photodiagnosis and photodynamic therapy.

[24]  R. Poulson The enzymic conversion of protoporphyrinogen IX to protoporphyrin IX in mammalian mitochondria. , 1976, The Journal of biological chemistry.

[25]  G. Durst Comparative Molecular Field Analysis (CoMFA) of Herbicidal Protoporphyrinogen Oxidase Inhibitors using Standard Steric and Electrostatic Fields and an Alternative LUMO Field , 1998 .

[26]  Nicholas J. Jacobs,et al.  Effect of diphenyl ether herbicides on oxidation of protoporphyrinogen to protoporphyrin in organellar and plasma membrane enriched fractions of barley. , 1991, Plant physiology.

[27]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[28]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[29]  C. Strick,et al.  Chloroplast-Diphenyl Ether Interactions II. , 1985, Plant physiology.

[30]  P. Labbé,et al.  Kinetic studies on protoporphyrinogen oxidase inhibition by diphenyl ether herbicides. , 1991, The Biochemical journal.

[31]  M. Shepherd,et al.  A continuous fluorimetric assay for protoporphyrinogen oxidase by monitoring porphyrin accumulation. , 2005, Analytical biochemistry.

[32]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[33]  Nicholas J. Jacobs,et al.  Protoporphyrinogen oxidation, an enzymatic step in heme and chlorophyll synthesis: partial characterization of the reaction in plant organelles and comparison with mammalian and bacterial systems. , 1984, Archives of biochemistry and biophysics.

[34]  Ge-Fei Hao,et al.  Computational mutation scanning and drug resistance mechanisms of HIV-1 protease inhibitors. , 2010, The journal of physical chemistry. B.

[35]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[36]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[37]  C. Gopi Mohan,et al.  Crystal Structure of Protoporphyrinogen Oxidase from Myxococcus xanthus and Its Complex with the Inhibitor Acifluorfen* , 2006, Journal of Biological Chemistry.

[38]  Guangfu Yang,et al.  The Role of Phe82 and Phe351 in Auxin-Induced Substrate Perception by TIR1 Ubiquitin Ligase: A Novel Insight from Molecular Dynamics Simulations , 2010, PloS one.

[39]  P. Labbé,et al.  Protoporphyrinogen oxidase as a molecular target for diphenyl ether herbicides. , 1989, The Biochemical journal.

[40]  H. Dailey,et al.  Human protoporphyrinogen oxidase: Expression, purification, and characterization of the cloned enzyme , 1996, Protein science : a publication of the Protein Society.

[41]  S. Duke,et al.  Biochemical and physiological effects of benzheterocycles and related compounds. , 1995 .

[42]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[43]  G. C. Ferreira,et al.  Organization of the terminal two enzymes of the heme biosynthetic pathway. Orientation of protoporphyrinogen oxidase and evidence for a membrane complex. , 1988, The Journal of biological chemistry.

[44]  W. Polglase,et al.  The enzymic conversion of protoporphyrinogen IX to protoporphyrin IX. Protoporphyrinogen oxidase activity in mitochondrial extracts of Saccharomyces cerevisiae. , 1975, The Journal of biological chemistry.

[45]  Samuel I. Beale,et al.  Enzymes of chlorophyll biosynthesis , 1999, Photosynthesis Research.

[46]  H. Klump,et al.  Kinetic and physical characterisation of recombinant wild-type and mutant human protoporphyrinogen oxidases. , 2003, Biochimica et biophysica acta.

[47]  H Abrahamse,et al.  Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. , 2009, Journal of photochemistry and photobiology. B, Biology.

[48]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[49]  K. Sharp,et al.  Accurate Calculation of Hydration Free Energies Using Macroscopic Solvent Models , 1994 .

[50]  Robert Huber,et al.  Crystal structure of protoporphyrinogen IX oxidase: a key enzyme in haem and chlorophyll biosynthesis , 2004, The EMBO journal.

[51]  Ge-Fei Hao,et al.  Understanding the mechanism of drug resistance due to a codon deletion in protoporphyrinogen oxidase through computational modeling. , 2009, The journal of physical chemistry. B.